Dr. Matthew Caleb Underwood is a pharmacist who is specialized in Pharmacotherapy in Chattanooga, Tennessee. Patients can reach him at 2525 Desales Ave, Chattanooga or contact him on 423-495-8380. Active license number of Dr. Matthew Caleb Underwood is 21806 for Pharmacotherapy in Tennessee. Dr. Matthew Caleb Underwood is a licensed pharmacist who has demonstrated specialized knowledge and skill in optimizing pharmacotherapeutic care of patients, by developing, implementing, monitoring, and modifying complex treatment plans, providing advanced level education and consultation, and collaborating with other health professionals in the management of therapy.
Complete Profile:
Dr. Matthew Caleb Underwood speciality, credentials, practice address, contact phone number and fax are as below. Patients can call on the below given phone number for enquiries.
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details of Dr. Matthew Caleb Underwood are as mentioned below.
NPI Number:
1386762292
NPI Enumeration Date:
27 Mar, 2007
NPI Last Update On:
08 Jul, 2007
Medical Licenses:
Pharmacists can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Dr. Matthew Caleb Underwood are as mentioned below.
Specialization
License Number
State
Status
Pharmacotherapy
21806
Tennessee
Primary
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address:
8907 Bear View Ln, Harrison, Tennessee
Zip:
37341-7662
Phone Number:
423-344-1650
Fax Number:
--
Patients can reach Dr. Matthew Caleb Underwood at 2525 Desales Ave, Chattanooga, Tennessee or can call on phone at 423-495-8380.
Comments/ Reviews:
*Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 11 November, 2024.